The Supreme Court’s decision in Loper Bright Enterprises, Inc. v. Raimondo and Relentless, Inc. v. Department of Commerce upended 40 years of judicial deference to administrative agencies’ interpretation of the statutes that they are tasked with implementing. Almost overnight, the federal regulatory framework that drives health care in the United States has shifted significantly. Please join Polsinelli for a series of one-hour discussions on the impact of the Supreme Court’s decision on various aspects of health care – including prospective compliance planning, enforcement defense, and advocacy in the post-Chevron world.

Part 1: Understanding New Opportunities and Challenges for Health Care Providers in a Post Chevron World

Thursday, July 25 | 12:00 PM - 1:00 PM CT

Health Care is one of the most regulated industries in the country and, for many years, the so-called “Chevron doctrine” has permitted Centers for Medicare & Medicaid Services (“CMS”) broad authority in regard to health care regulation and reimbursement. With the Supreme Court’s recent decisions dismantling the judicial system’s deference to administrative agencies, health care providers will need to rethink their strategies with respect to regulatory compliance. Join Polsinelli for a discussion of what to expect in a post-Chevron world and the potential opportunities and challenges for health care providers across the industry, including:

• Short and long-term expectations for the regulation of health care moving forward
• Specific areas of health care regulation that may be impacted
• New opportunities (and some potential conundrums) for providers to challenge regulations
• Strategic considerations for audits and appeals

If you have questions or would like more information regarding this webinar, please contact webinars@polsinelli.com.

Register for other events in this series:

Part 1: Understanding New Opportunities and Challenges for Health Care Providers in a Post Chevron World

Part 2: Post-Chevron Outlook in Congress

Part 3: Privacy and AI Regulation: Repeal of Chevron Deference Puts Congress in Driver Seat

Part 4: Navigating Through the Employment Laws and Regulations in a Post-Chevron World

Part 5: Resolving FDA Disputes without the Chevron Shield; Strategies for an Uncertain World

Part 6: No Deference to the EPA: Bombshell or NBD? How the Repeal of Chevron Impacts Environmental Regulation